Lantheus Medical Imaging has renewed its long-term licensing and distribution deal with Fujifilm RI Pharma covering SPECT imaging agents Cardiolite and Neurolite. As part of the 10-year deal, which took effect Jan. 1, Lantheus will keep providing FRI with the agents in finished form for distribution in Japan. Lantheus will also supply raw materials for developing and marketing in unit dose format.
Lantheus extends SPECT agents deal with Japanese firm
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||